An evaluation of metabolic risks for coronary death in the Asia Pacific region
Introduction
The metabolic syndrome is associated with increased risk of developing coronary heart disease (CHD) [1], [2]. Most clinical definitions of the metabolic syndrome, including the definition most recently produced by the International Diabetes Federation [3], require dichotomizing and then counting individual risk factors. This also includes the US National Cholesterol Education Program—Adult Treatment Panel III (NCEP-ATPIII) definition [4], which requires at least three of the following five risk factors to be present—hypertension, hypertriglyceridaemia, low levels of high density lipoprotein (HDL) cholesterol, hyperglycaemia and abdominal obesity. Therefore, establishing a diagnosis of the metabolic syndrome in an individual requires establishing the presence or absence of each of these risk factors, based on NCEP-defined threshold values.
Estimating an individual's risk of developing CHD based on “counting” of traditional coronary risk factors has the potential for poor specificity and sensitivity [5]. Instead, methods based on multivariable equations (e.g. Framingham risk functions) to estimate CHD risk more accurately are now almost universally incorporated into therapeutic guidelines worldwide [4], [6]. The theoretical considerations underpinning this approach for traditional CHD risk factors apply also to “metabolic” risk factors. Blood pressure, triglycerides, HDL cholesterol, fasting blood glucose, and measures of obesity have each been shown to be associated independently with the risk of CHD [7], [8], [9], [10], [11]. These associations are described as continuous and log-linear, such that threshold values to define abnormality cannot be clearly identified. Even if categorization of continuous risk factors is considered clinically useful, the generalizability of threshold values to define abnormality is unclear. Physicians and researchers in many Asian countries frequently rely on the guidelines and clinical definitions primarily developed from North American populations [12], [13].
The Asia Pacific Cohort Studies Collaboration (APCSC) is an individual participant data meta-analysis of prospective studies conducted in the Asia-Pacific region. Using these data, we examine the generalizability of NCEP-ATPIII metabolic syndrome cut-points for discriminating CHD risk in populations in the Asia-Pacific region. We further compare different methods of defining metabolic risks for CHD in this region, using a variety of mathematical models.
Section snippets
Materials and methods
The design of APCSC, an individual participant data meta-analysis of cohort studies conducted in the Asia-Pacific region, has been reported elsewhere [14]. Studies were classified as “Asian” if participants were recruited from Mainland China, Hong Kong, Japan, Korea, Singapore, Taiwan or Thailand, or “ANZ” if participants were recruited from Australia or New Zealand. Each study reported deaths by underlying cause. The current analyses were restricted to fatal CHD, as classified according to the
Results
The cohorts included in the current analyses, and the characteristics of these studies at baseline are described in Table 1.
Discussion
These analyses confirm that individuals in the Asia-Pacific region with high levels of multiple “metabolic” risk factors are at increased risk of CHD death. However, using the modified NCEP-ATPIII definition as an example, we demonstrate that definitions of the metabolic syndrome requiring dichotomizing and “counting” of risk factors discriminate CHD risk substantially less well than those that utilize these risk factors as continuous variables. Even if cut-points are considered necessary for
Acknowledgements
Funding/Support: APCSC has received grants from the National Health and Medical Research Council of Australia and the Health Research Council of New Zealand, and an unrestricted educational grant from Pfizer Inc.
References (26)
- et al.
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
Lancet
(2005) - et al.
The US National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII) prevalence of the metabolic syndrome in a Chinese population: the Hong Kong Cardiovascular Risk Factor Study
Diabetes Res. Clin. Pract.
(2005) - et al.
Prevalence of the metabolic syndrome and overweight among adults in China
Lancet
(2005) - et al.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study
Lancet
(2004) - et al.
Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women
Arch. Intern. Med.
(2004) - et al.
National cholesterol education program versus world health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study
Circulation
(2004) - International Diabetes Federation Worldwide Definition of the Metabolic Syndrome [article online], 2005. Available from...
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
JAMA
(2001)- et al.
Joint British recommendations on prevention of coronary heart disease in clinical practice: summary
Br. Med. J.
(2000) Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts
Lancet
(1995)
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia Pacific region
Circulation
Blood glucose and risk of cardiovascular disease in the Asia Pacific region
Diabetes Care
High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study
Am. J. Epidemiol.
Cited by (21)
Body Composition in Asians and Caucasians: Comparative Analyses and Influences on Cardiometabolic Outcomes
2015, Advances in Food and Nutrition ResearchCitation Excerpt :For hypertension, the cutoffs were 24 and 24 kg/m2 for BMI, 0.92 and 0.84 for WHR, and 85 cm and 80 cm for WC in men and women, respectively. Similarly, the Asia Pacific Cohort Studies Collaboration containing data from 329,166 participants and 26 cohorts found that for CHD death, the cutoff for Asians for BMI was 24 kg/m2 in both genders, whereas in non-Asian cohorts living in Australia and New Zealand, the optimal cutoffs were 28 and 25 kg/m2 in men and women, respectively (Asia Pacific Cohort Studies Collaboration, 2006b). Majority of the reviews and original research undertaken in Asians to explore cutoffs have relied on cross-sectional data and mainly used receiving operating characteristics (ROC) to calculate cutoff values that gave the best combination of sensitivity and specificity.
Gender differences in the association of insulin resistance with metabolic risk factors among Korean adolescents: Korea National Health and Nutrition Examination Survey 2008-2010
2013, Diabetes Research and Clinical PracticeCitation Excerpt :Metabolic syndrome (MetS), which is the clustering of glucose intolerance, dyslipidemia, hypertension, and central obesity, has been widely recognized as a risk factor for type 2 diabetes and cardiovascular disease among adults [1,2].
The asia pacific cohort studies collaboration: A decade of achievements
2012, Global HeartCitation Excerpt :Day-to-day management is undertaken through a secretariat at the George Institute in Australia. To date, APCSC has published 52 peer-reviewed publications [1–52]. Apart from the initial protocol [1], all were published from 2003 to 2012.
Metabolic syndrome and incidence of liver and breast cancers in Japan
2012, Cancer EpidemiologyRisk factors for the metabolic syndrome in contemporary China
2009, CVD Prevention and Control
- 1
Writing Committee: A. Patel, F. Barzi, M. Woodard, C. Ni Mhurchu, T. Ohkubo, T.H. Lam, T. Welborn. Executive Committee: M. Woodward, X. Fang, D.F. Gu, Y. Imai, T.H. Lam, W.H. Pan, A. Rodgers, I. Suh, H.J. Sun, H. Ueshima. Statistical Analyses: F. Barzi, V. Parag, M. Woodward. Participating studies and principal collaborators in APCSC: Aito Town: A. Okayama, H. Ueshima, H. Maegawa; Akabane: M. Nakamura, N. Aoki; Anzhen02: Z.S. Wu; Anzhen: C.H. Yao, Z.S. Wu; Australian Longitudinal Study of Aging: G. Andrews; Australian National Heart Foundation: T.A. Welborn; Beijing Aging: Z. Tang; Beijing Steelworkers: L.S. Liu, J.X. Xie; Blood Donors’ Health: R. Norton, S. Ameratunga, S. MacMahon, G. Whitlock; Busselton: M.W. Knuiman; Canberra-Queanbeyan: H. Christensen; Capital Iron and Steel Company: X.G. Wu; CISCH: J. Zhou, X.H. Yu; Civil Service Workers: A. Tamakoshi; CVDFACTS: W.H. Pan; East Beijing: Z.L. Wu, L.Q. Chen, G.L. Shan; Electricity Generating Authority of Thailand: P. Sritara; Fangshan: D.F. Gu, X.F. Duan; Fletcher Challenge: S. MacMahon, R. Norton, G. Whitlock, R. Jackson; Guangzhou: Y.H. Li; Guangzhou Occupational: T.H. Lam, C.Q. Jiang; Hisayama: M. Fujishima, Y. Kiyohara, H. Iwamoto; Hong Kong: J. Woo, S.C. Ho; Huashan: Z. Hong, M.S. Huang, B. Zhou; Kinmen: J.L. Fuh; Konan: H. Ueshima, Y. Kita, S.R. Choudhury; KMIC: I. Suh, S.H. Jee, I.S. Kim; Melbourne: G.G. Giles; Miyama: T. Hashimoto, K. Sakata; Newcastle: A. Dobson; Ohasama: Y. Imai, T. Ohkubo, A. Hozawa; Perth: K. Jamrozik, M. Hobbs, R. Broadhurst; Saitama: K. Nakachi; Seven Cities: X.H. Fang, S.C. Li, Q.D. Yang; Shanghai Factory Workers: Z.M. Chen; Shibata: H. Tanaka; Shigaraki Town: Y. Kita, A. Nozaki, H. Ueshima; Shirakawa: H. Horibe, Y. Matsutani, M. Kagaya; Singapore Heart: K. Hughes, J. Lee; Singapore NHS92: D. Heng, S.K. Chew; Six Cohorts: B.F. Zhou, H.Y. Zhang; Tanno/Soubetsu: K. Shimamoto, S. Saitoh; Tianjin: Z.Z. Li, H.Y. Zhang; Western Australia AAA Screenees: P. Norman, K. Jamrozik; Xi’an: Y. He, T.H. Lam; Yunnan: S.X. Yao.